16-50749785-C-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001378743.1(CYLD):c.87C>T(p.Ser29=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,613,752 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 33 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 33 hom. )
Consequence
CYLD
NM_001378743.1 synonymous
NM_001378743.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0280
Genes affected
CYLD (HGNC:2584): (CYLD lysine 63 deubiquitinase) This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
?
Variant 16-50749785-C-T is Benign according to our data. Variant chr16-50749785-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 695378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-50749785-C-T is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=0.028 with no splicing effect.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.011 (1681/152138) while in subpopulation AFR AF= 0.0385 (1595/41472). AF 95% confidence interval is 0.0369. There are 33 homozygotes in gnomad4. There are 760 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High AC in GnomAd at 1675 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYLD | NM_001378743.1 | c.87C>T | p.Ser29= | synonymous_variant | 3/19 | ENST00000427738.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYLD | ENST00000427738.8 | c.87C>T | p.Ser29= | synonymous_variant | 3/19 | 5 | NM_001378743.1 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.0110 AC: 1675AN: 152020Hom.: 33 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
1675
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00268 AC: 668AN: 249170Hom.: 17 AF XY: 0.00207 AC XY: 280AN XY: 135190
GnomAD3 exomes
AF:
AC:
668
AN:
249170
Hom.:
AF XY:
AC XY:
280
AN XY:
135190
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00112 AC: 1632AN: 1461614Hom.: 33 Cov.: 32 AF XY: 0.000974 AC XY: 708AN XY: 727106
GnomAD4 exome
AF:
AC:
1632
AN:
1461614
Hom.:
Cov.:
32
AF XY:
AC XY:
708
AN XY:
727106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0110 AC: 1681AN: 152138Hom.: 33 Cov.: 32 AF XY: 0.0102 AC XY: 760AN XY: 74394
GnomAD4 genome
?
AF:
AC:
1681
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
760
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 24, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at